Overview

Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
0
Participant gender:
All
Summary
Using a virtual reality program in screening and treatment of ADHD.
Phase:
Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Shaare Zedek Medical Center
Treatments:
Methylphenidate
Criteria
Inclusion Criteria:

Clinical diagnosis of ADHD-DSM4 criteria AGE 10-20 YEARS normal neurological examination
IQ>80

Exclusion Criteria:

ABNORMAL NEUROLOGICAL STATUS